World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 13 April 2015
Main ID:  NCT02207387
Date of registration: 28/07/2014
Prospective Registration: No
Primary sponsor: University of British Columbia
Public title: Ambulosono Rasagiline Musical Walking Study
Scientific title: A Sensorimotor Contingency-based Musical Walking Program for People Living With Parkinson's Disease
Date of first enrolment: October 2013
Target sample size: 60
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02207387
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Canada
Contacts
Name:     Tammy Kang
Address: 
Telephone: 604 822 9722
Email: tammy.kang@ubc.ca
Affiliation: 
Name:     Martin J McKeown, MD
Address: 
Telephone:
Email:
Affiliation:  University of British Columbia
Name:     Silke Cresswell, MD
Address: 
Telephone:
Email:
Affiliation:  University of British Columbia
Key inclusion & exclusion criteria

Inclusion Criteria:

- Over 19 years of age

- Confirmed diagnosis of Parkinson's Disease

- Can walk 5 to 10 minutes unassisted

- Have a safe place to walk (outdoor or indoor)

- Have mild to moderate Parkinson's disease (HY1-3)

- Be able to lay flat in the scanner for the period of the study

- No reliance on wheelchair or other walking aid for ambulation

- Absence of any other serious medical conditions such as hearing impairment and
dementia

- No history of other neurological and psychiatric illnesses

- No recent musculoskeletal impairment or injuries that may prevent walking

Exclusion Criteria:

- Under 19 years of age

- Unconfirmed PD diagnosis

- Require walking aid, wheelchair-bound

- No access to safe walking pathway

- Severe PD (Hoehn & Yahr stages>3)

- Impaired hearing

- Atypical Parkinsonism

- Concurrent dementia

- Recent knee, hip or foot injury (need permission from doctor)

Exclusion Criteria for fMRI

- Pacemaker

- Brain aneurysm clip

- Cochlear implant

- Recent surgery within the past 6 weeks

- Possibility of pregnancy

- Electrical stimulator for nerves or bones

- Implanted infusion pump

- History of any eye injury involving metal fragments

- History of working with metals (grinding, machining, or welding)

- Artificial heart valve

- Orthopaedic hardware (artificial joint, plate, screws, rods)

- Other metallic prostheses

- Coil, catheter or filter in any blood vessel

- Ear or eye implant

- Recent tattoos within the past 6 weeks

- Shrapnel, bullets, or other metallic fragments

- Medication releasing skin patches (nicotine, birth control, nitroglycerine)



Age minimum: 19 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Parkinson's Disease
Intervention(s)
Drug: Azilect
Behavioral: Exercise
Other: Music
Primary Outcome(s)
Change from baseline in brain imaging signals (fMRI) [Time Frame: one month and four months]
Secondary Outcome(s)
Change from baseline in cognition of PD [Time Frame: baseline and one month and four months]
Change from baseline in motor symptoms of PD [Time Frame: baseline and one month and four months]
Secondary ID(s)
H13-02074
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Teva Pharmaceutical Industries
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history